US equities
|
NVDA
$204.64
▼-4.22%
INTC
$65.76
▼-28.58%
MU
$884.74
▼-5.30%
AMZN
$240.35
▼-1.41%
AAPL
$344.63
▼-1.23%
SNDK
$1,150.89
▼-13.47%
AMD
$504.80
▼-10.88%
MSFT
$521.91
▼-1.55%
NVDA
$204.64
▼-4.22%
INTC
$65.76
▼-28.58%
MU
$884.74
▼-5.30%
AMZN
$240.35
▼-1.41%
AAPL
$344.63
▼-1.23%
SNDK
$1,150.89
▼-13.47%
AMD
$504.80
▼-10.88%
MSFT
$521.91
▼-1.55%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Tools
My watchlist
My portfolio
Recent quotes
Ortho Clinical Diagnostics Holdings plc - Ordinary Shares
(NQ:
OCDX
)
N/A
UNCHANGED
Last Price
Updated: 4:00 PM EDT, May 26, 2022
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Ortho Clinical Diagnostics Holdings plc - Ordinary Shares
Quidel and Ortho Announce Expected Closing of Ortho Transaction
May 26, 2022
From
Quidel Corporation
Via
Business Wire
NASDAQ:OCDX Investor Alert: Investigation of Takeover of Ortho Clinical Diagnostics Holdings Plc
↗
March 25, 2022
San Diego, CA -- (SBWIRE) -- 03/25/2022 -- An investigation was announced concerning whether the takeover of Ortho Clinical Diagnostics Holdings plc is unfair to NASDAQ:OCDX stockholders.
Via
SBWire
Benzinga's Top Ratings Upgrades, Downgrades For February 17, 2022
↗
February 17, 2022
Upgrades HSBC upgraded the previous rating for Equinor ASA (NYSE:EQNR) from Hold to Buy. For the fourth quarter, Equinor had an EPS of $1.35, compared to year-ago quarter EPS of $...
Via
Benzinga
Ortho Clinical Diagnostics' Q4 EPS Beat Estimates
↗
February 17, 2022
Ortho Clinical Diagnostics Holdings plc (NASDAQ: OCDX)
Via
Benzinga
Earnings Scheduled For February 16, 2022
↗
February 16, 2022
Companies Reporting Before The Bell • Wix.com (NASDAQ:WIX) is projected to report quarterly loss at $0.38 per share on revenue of $331.16 million.
Via
Benzinga
Ortho Clinical Diagnostic: Q4 Earnings Insights
↗
February 16, 2022
Ortho Clinical Diagnostic (NASDAQ:OCDX) reported its Q4 earnings results on Wednesday, February 16, 2022 at 04:30 PM. Here's what investors need to know about the announcement.
Via
Benzinga
Ortho Clinical Diagnostic Earnings Preview
↗
February 15, 2022
Ortho Clinical Diagnostic (NASDAQ:OCDX) is set to give its latest quarterly earnings report on Wednesday, 2022-02-16. Here's what investors need to know before the announcement. Analysts estimate that...
Via
Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
↗
February 04, 2022
Gainers Quidel (NASDAQ:QDEL) shares incre...
Via
Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
↗
February 03, 2022
Gainers Cidara Therapeutics (NASDAQ:CDTX)...
Via
Benzinga
10 Biggest Price Target Changes For Monday
↗
December 27, 2021
Morgan Stanley cut Foot Locker, Inc. (NYSE:FL) price...
Via
Benzinga
CROX Stock: The $2.5B HEYDUDE Deal That Has Crocs Investors Crying Today
↗
December 23, 2021
Crocs (CROX) stock isn't doing so hot on Thursday after the footwear company announced a massive $2.5 billion deal for HEYDUDE.
Via
InvestorPlace
OCDX Stock Alert: 9 Things to Know About the Quidel Deal Sending Ortho Clinical Higher
↗
December 23, 2021
Quidel will acquire OCDX stock for $24.68 per share and newly issued stock. The transaction will be worth a total of $6 billion.
Via
InvestorPlace
Ortho Clinical (OCDX) Stock Alert: Halper Sadeh LLP Announces Investigation Into Whether the Sale of Ortho Clinical Diagnostics Holdings PLC Is Fair to Shareholders; Investors Are Encouraged to Contact the Firm – OCDX
December 23, 2021
From
Halper Sadeh LLP
Via
Business Wire
Tesla Leads Automobile Stocks to be Among Wednesday's Top Performers
↗
December 23, 2021
Stock index futures point higher as investors look to add to two days of gains. Thursday is the last trading day of the week because markets are closed on Friday in observance of...
Via
Benzinga
Quidel To Buy Ortho Clinical Diagnostics For $24.68/Share: Highlights
↗
December 23, 2021
Quidel Corp (NASDAQ: QDEL) has agreed to acquire Ortho Clinical Diagnostics Holdings plc (NASDAQ: OCDX) for $24.68 per share in cash and newly issued shares in...
Via
Benzinga
Quidel Corporation Signs Definitive Agreement to Acquire Ortho Clinical Diagnostics
December 23, 2021
From
Quidel Corporation
Via
Business Wire
Free COVID Tests: What Stocks Will Benefit?
↗
December 23, 2021
The government hasn’t announced yet what company or companies it will be buying from, but there are several businesses involved in producing these kits.
Via
Talk Markets
Ortho Clinical Diagnostics Holdings plc (OCDX) Q3 2021 Earnings Call Transcript
↗
November 04, 2021
OCDX earnings call for the period ending September 30, 2021.
Via
The Motley Fool
Topics
Earnings
The Daily Biotech Pulse: Cerus Climbs On Earnings, Horizon CFO To Retire, Teva Prices Upsized Sustainability-Linked Senior Note Offering
↗
November 03, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus Horizon Announces Retirement Of CFO, Beat-and-raise Q3 Horizon Therapeutics...
Via
Benzinga
Topics
Retirement
Ortho Clinical Diagnostics Holdings plc (OCDX) Q2 2021 Earnings Call Transcript
↗
August 05, 2021
OCDX earnings call for the period ending June 30, 2021.
Via
The Motley Fool
Topics
Earnings
Covid-19 Tests Innovations Drawing New Interest from FDA and Consortiums
July 22, 2021
Via
FinancialNewsMedia
The Week Ahead In Biotech (Oct. 31-Nov. 6): Earnings Pick Up Pace, Eton Awaits Seizure Drug Approval, Kidney Conference, More IPOs In The Pipeline
↗
October 31, 2021
Biotech stocks rose a third week running in the week ending Oct. 29 amid positive reaction to earnings. Big pharma earnings were mostly better than expected. Merck & Co, Inc...
Via
Benzinga
The Daily Biotech Pulse: Apellis Sinks On Data, Endo Shines On Opioid Litigation Settlement, T2 Biosystems Soars On Mutant Detection Ability of COVID Test
↗
September 10, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 9) Adagio Therapeutics, Inc. (...
Via
Benzinga
Ortho Clinical Diagnostics' COVID-19 Antibody Test Gets FDA Emergency Use Approval
↗
July 12, 2021
The FDA has granted Emergency Use Authorization (EUA) to Ortho Clinical Diagnostics' (NASDAQ: OCDX) VITROS Anti-SARS-CoV-2 IgG Quantitative Test. The...
Via
Benzinga
Ortho Clinical Diagnostics Holdings plc (OCDX) Q1 2021 Earnings Call Transcript
↗
May 06, 2021
OCDX earnings call for the period ending March 31, 2021.
Via
The Motley Fool
Topics
Earnings
48 Biggest Movers From Yesterday
↗
September 10, 2021
Gainers Rocket Lab USA, Inc. (NASDAQ: RKLB) jumped 37.3% to settle at $20.72. Rocket Lab reported 1H sales of $29.5 million and announced it has been awarded a contract to deploy...
Via
Benzinga
The Daily Biotech Pulse: AstraZeneca, Biogen Face Clinical Trial Disappointments, Novavax Studies Coronavirus-Flu Combo Vaccine, Decision Day For Takeda
↗
June 15, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 14) Alkermes plc (NASDAQ: ALKS...
Via
Benzinga
The Daily Biotech Pulse: Quidel Slides On Negative Pre-Announcement, Roche Gets Positive EMA Committee Recommendation, 3 IPOs
↗
April 23, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 22) AtriCure, Inc. (NASDAQ:...
Via
Benzinga
